Inner Mongolia Autonomous Region Center for Diseases Prevention and Control (IMCDC) Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2015
NCT04223037
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Disease prevention and control center of Inner Mongolia autonomous region | Inner Mongolia Autonomous Region Center for Diseases Prevention and Control

Active Ingredients

Drugs in Phase 4 Trials (2)

bivalent oral polio vaccine (bopv), type 1 and type 3 (1 trial)

ipv (1 trial)

Drugs in Phase 3 Trials (1)

inactivated japanese encephalitis vaccine (Ixiaro) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Encephalitis (Phase 3)

Encephalitis, Japanese (Phase 3)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3